U.S. STOCKS ON THE MOVE-Tenet Healthcare, Intel, Verizon
BUZZ-U.S. STOCKS ON THE MOVE-Tenet Healthcare, Intel, Verizon July 24 (Reuters) - U.S. stock index futures edged higher on Friday after a tech-led selloff in the previous session, as investors weighed fresh earnings, escalating Middle East tensions and a new tariff announcement from the Trump administration. .N
** Deckers Outdoor Corp DECK.N:
BUZZ - Falls after maintaining annual sales forecast nL4N43Q0VB
** American Express Co AXP.N:
BUZZ - Results seen climbing in Q2; investors focus on affluent customers nL6N43P1BY
** Tenet Healthcare Corp THC.N:
BUZZ - Jumps after lifting annual forecast nL4N43Q0TL
** Intel Corp INTC.O:
BUZZ - Climbs as profit forecast above estimates nL6N43Q0N7
** MannKind Corp MNKD.O:
BUZZ - Climbs as FDA approves drug-device combo for fluid buildup nL4N43Q0VH
** Verizon Communications Inc VZ.N:
BUZZ - Rises after raising annual profit forecast nL4N43Q0T4
** SLB NV SLB.N:
BUZZ - Gains on second-quarter profit beat nL4N43Q0VI
** Summit Therapeutics Inc SMMT.O:
BUZZ - Falls after share sale plans, Q2 report nL6N43Q0RJ
(Rajarshi Roy and Prathik Jayaprakash)
((Rajarshi.Roy@thomsonreuters.com Prathik.Jayaprakash@tomsonreuters.com))
Recent news on Summit Therapeutics
See all newsBrief: Akeso Announces Summit Therapeutics And Ecog-Acrin Cancer Research Group Enter Into Phase Ii/Iii Clinical Trial Collaboration To Evaluate Ivonescimab In First-Line Biliary Tract Cancer
Factbox: Major drugmakers turn to China for licensing deals
Brief: Summit Therapeutics Announces Opening Of Global Phase Ii Study Of Ivonescimab-Based Regimens In Advanced Clear Cell Renal Cell Carcinoma
Factbox: Major drugmakers turn to China for licensing deals
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination (updated)